Changes in electrokinetic properties of erythrocytes under the influence of pentoxifylline and new hemorheologically active substances. 2012

L V Naumenko, and V A Kuznetsov, and A A Spasov, and A V Muravyev, and I A Tikhomirova, and F A Khaliullin, and V A Anisimova
Department of Pharmacology, Volgograd State Medical University, Rostov-on-Don, Russia. milanaumenko@mail.ru

We studied the impact of compounds RU-1202 and SUM-55 on electrophoretic mobility of "young" and "old" erythrocytes fractionated in a density gradient. The test compounds are shown to increase electrophoretic mobility of erythrocytes, compound SUM-55 being superior to the reference drug pentoxifylline.

UI MeSH Term Description Entries
D008297 Male Males
D010431 Pentoxifylline A METHYLXANTHINE derivative that inhibits phosphodiesterase and affects blood rheology. It improves blood flow by increasing erythrocyte and leukocyte flexibility. It also inhibits platelet aggregation. Pentoxifylline modulates immunologic activity by stimulating cytokine production. Agapurin,BL-191,Oxpentifylline,Pentoxil,Torental,Trental,BL 191,BL191
D010880 Piperidines A family of hexahydropyridines.
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D004910 Erythrocyte Membrane The semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS. Erythrocyte Ghost,Red Cell Cytoskeleton,Red Cell Ghost,Erythrocyte Cytoskeleton,Cytoskeleton, Erythrocyte,Cytoskeleton, Red Cell,Erythrocyte Cytoskeletons,Erythrocyte Ghosts,Erythrocyte Membranes,Ghost, Erythrocyte,Ghost, Red Cell,Membrane, Erythrocyte,Red Cell Cytoskeletons,Red Cell Ghosts
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.
D014970 Xanthines Purine bases found in body tissues and fluids and in some plants.

Related Publications

L V Naumenko, and V A Kuznetsov, and A A Spasov, and A V Muravyev, and I A Tikhomirova, and F A Khaliullin, and V A Anisimova
June 1985, Angiology,
L V Naumenko, and V A Kuznetsov, and A A Spasov, and A V Muravyev, and I A Tikhomirova, and F A Khaliullin, and V A Anisimova
November 1989, Angiology,
L V Naumenko, and V A Kuznetsov, and A A Spasov, and A V Muravyev, and I A Tikhomirova, and F A Khaliullin, and V A Anisimova
August 1974, Biulleten' eksperimental'noi biologii i meditsiny,
L V Naumenko, and V A Kuznetsov, and A A Spasov, and A V Muravyev, and I A Tikhomirova, and F A Khaliullin, and V A Anisimova
August 1977, Biokhimiia (Moscow, Russia),
L V Naumenko, and V A Kuznetsov, and A A Spasov, and A V Muravyev, and I A Tikhomirova, and F A Khaliullin, and V A Anisimova
January 2000, Fiziologiia cheloveka,
L V Naumenko, and V A Kuznetsov, and A A Spasov, and A V Muravyev, and I A Tikhomirova, and F A Khaliullin, and V A Anisimova
June 1996, Indian journal of biochemistry & biophysics,
L V Naumenko, and V A Kuznetsov, and A A Spasov, and A V Muravyev, and I A Tikhomirova, and F A Khaliullin, and V A Anisimova
January 1959, Acta biologica et medica Germanica,
L V Naumenko, and V A Kuznetsov, and A A Spasov, and A V Muravyev, and I A Tikhomirova, and F A Khaliullin, and V A Anisimova
January 1960, Biofizika,
L V Naumenko, and V A Kuznetsov, and A A Spasov, and A V Muravyev, and I A Tikhomirova, and F A Khaliullin, and V A Anisimova
February 1973, Biulleten' eksperimental'noi biologii i meditsiny,
L V Naumenko, and V A Kuznetsov, and A A Spasov, and A V Muravyev, and I A Tikhomirova, and F A Khaliullin, and V A Anisimova
February 1975, Tsitologiia,
Copied contents to your clipboard!